{
    "organizations": [],
    "uuid": "95807a9af37e6eb162b97e6195ee05088cbd7001",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSFWN1QP0XJ",
    "ord_in_thread": 0,
    "title": "REFILE-BRIEF-Argos Therapeutics' Cash And Cash Equivalents About $15.2 Mln At Year End",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "(Fixes typo in headline)\nMarch 7 (Reuters) - Argos Therapeutics Inc:\n* ARGOS THERAPEUTICS INC SAYS ESTIMATES THAT ITS CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017 WERE ABOUT $15.2 MILLION\n* ARGOS THERAPEUTICS - EXPECTS THAT ITS CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS THROUGH END OF 2018 Source text ( bit.ly/2Id9za7 ) Further company coverage:\n ",
    "published": "2018-03-08T06:20:00.000+02:00",
    "crawled": "2018-03-08T17:10:50.056+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "fix",
        "typo",
        "headline",
        "march",
        "reuters",
        "argo",
        "therapeutic",
        "inc",
        "argo",
        "therapeutic",
        "inc",
        "say",
        "estimate",
        "cash",
        "cash",
        "equivalent",
        "dec",
        "million",
        "argo",
        "therapeutic",
        "expects",
        "current",
        "cash",
        "cash",
        "equivalent",
        "sufficient",
        "fund",
        "operation",
        "end",
        "source",
        "text",
        "company",
        "coverage"
    ]
}